Ingaba lo Uncedo lwe-Thiamine-Okhutshiweyo lweNcediso?
I-Benfotiamine yinto ephuma kwi-thiamine (i-vitamin B eyaziwayo njenge-vitamin B1). Kuthetha ukuba i-benfotiamine ephakanyiswayo iphakamisa amanqanaba akho e-thiamine kwaye, ngokukhawuleza, ikhusela kwiimeko zempilo ezinxulumene namazinga aphantsi kwe-thiamine.
I-thiamine ifumaneka kwiindawo ezahlukeneyo zokutya okubandakanya inyama, inkukhu, amaqanda, kunye neenqanawa ezinqatyisiweyo ezifana nesonka, okusanhlamvu, i-pasta, ilayisi kunye nomgubo.
Abantu abondla kakhulu i-carbohydrate ecocekileyo (njengelayisi omhlophe kunye nemveliso yepompo emhlophe engagqityiweyo) okanye ukuphepha i-grains ingaba mngcipheko omkhulu wokunqongophala kwe-thiamine, njengabo banesifo sohudo olude, Isifo sikaCrohn kunye nokuxhomekeka kotywala. Ukuzivocavoca okunzima kunye neemeko ezifana ne-hyperthyroidism zonyusa isidingo somzimba we-thiamine.
Ukusetyenziswa
Amanqanaba amancinci amancinci anxulumene neengxaki zezempilo, kubandakanywa iziphazamiso zesibindi kunye nentliziyo. Ekubeni i-benfotiamine ibonakala ibe neyona nto ifikeleleke kakhulu kwaye iyanqandwa ngumzimba ngaphezu kwe-thiamine, abanye abantu bayayisebenzisela ukunyusa izinga labo be-thiamine nokulawula iimeko ezithile zempilo.
Ngokomzekelo, i-benfotiamine idla ngohlobo lwemvelo kwimiqathango elandelayo:
- Ukuxhalabisa
- Umqolo obuhlungu
- Ukuxinezeleka
- Sikashukela
- FIbromyalgia
- I-neuropathy (kubandakanywa neuropathy neuropathy neuropathy)
- Sciatica
- Isifo se-Thyroid (njengesifo sikaHashimoto)
Ukongezelela, i-benfotiamine kuthiwa iphucise inkqubo yokuguga, ukuphucula ukusebenza komzimba, ukunyusa umoya, ukuphucula ukusebenza kwengqondo, nokunciphisa i-lactic acid buildup emzimbeni.
Abanye abaxhasayo baphakamisa ukuba i-benfotiamine inokukhusela umzimba kwimiphumo emibi yemveliso ekupheleni kwe-glycation (AGEs).
Uhlobo lwenkqutyana olutholakala kwinyama kunye nokutya okunye (ngokukhatyiweyo, okugongwe, okubhakiweyo, okanye ukutya okutyongweyo), ii-AGE zingabangela ukuvuvukala kunye negalelo kwimibandela yempilo.
Izinzuzo
Okwangoku, izifundo ezimbalwa zihlolisise iingeniso zempilo ezinokuthi zithathe i-benfotiamine supplements. Nanku ukukhangela kwezinye iziphumo zophando eziphambili:
1) Isifo sikashukela
I-Benfotiamine inokuba yinzuzo kwabanye abantu abanesifo sikashukela, ngokubhekiselele kuphando olupapashwe kwiNtsholongwane kaGawulayo ngo-2006. Ukufunda, abantu aba-13 abanesifo sikashukela banikezwa isidlo kunye nomxholo ophezulu we-AGE ngaphambi kokuba emva kweentsuku ezintathu zokudla ezili-1,050 mg we-benfotiamine imihla ngemihla. Iziphumo zoFundo zibonise ukuba i-benfotiamine ibonakala ikhusele ukuxinzezeleka kwengcinezelo eyenziwa yi-AGEs.
Ngophando luka-2010 olupapashwe kwiNtsholongwane kaGawulayo, ke ke, abaphandi baphando ngomphumo we-benfotiamine kubantu abane-type 2 yeswekile kunye ne-nephropathy. Kuhlolisiso, abathathi-nxaxheba bathatha i-benfotiamine okanye i-placebo kwimizuzu eyi-12 imihla ngemihla. Iziphumo zityhila ukuba i-benfotiamine ayizange iyanciphise ukuvota kwe-albin yangaphandle (uvavanyo olusetyenziswa ukujonga isifo sengqondo) okanye amanqanaba e-KIM-1 (ummakishi wokulimala kwentso).
Uphando lweveki eli-12 olupapashwe kwi- PLoS One ngo-2012 kwakhona lufumene ukuba i-benfotiamine ayinakuchaphazela ngokuphawulekayo abamakishi abakhokelela kwiingxaki ze-vascular hyperglycemia.
Idibeneyo: Izilwanyana zendalo zesifo sikashukela
2) I-Neuropathy ye-Diabetes
Izifundo ezincinane ezincinci zibonisa ukuba i-benfotiamine inokunceda ekhatyweni kwe-diabetes neuropathy (imeko ephawulwe ngumonakalo wesondlo obangela ukuphakama kwe-diabetes ephezulu kwizinga leshukela legazi).
Uvavanyo olwenziwa ngo-2012 oluvela kwiNtsholongwane kaGawulayo, nangona kunjalo, lafumanisa ukuba iinyanga ezingama-24 zonyango kunye ne-benfotiamine zazingenayo imiphumo ebalulekileyo kumsebenzi wentsholongwane okanye kumakishi wokuvuvukala kwabathathi-nxaxheba abane-type 1 yeswekile.
3) Izifo ze-Alzheimer's
UBenfotiamine ubonisa isithembiso sokunyangwa kwesifo se-Alzheimer , ngokutsho kwincwadana encinci ye-2016 epapashwe kwi- Neuroscience Bulletin .
Abathathi-nxaxheba abahlanu abane-Alzheimer's mildly to moderate disease bathatha i-benfotiamine (300 mg ngosuku) kwiinyanga ezili-18.
Ekupheleni kokufunda, abathathi-nxaxheba bathathu babonisa ukuphuculwa kwengqondo. Abaphandi bavavanya abathathu abathathi-nxaxheba nge-PET scan kwaye bafumanisa ukuphuculwa xa kuthelekiswa neendlela zabo zokuqala.
Iimiphumo zangaphandle
Nangona uncinci luyaziwa ngokukhusela ukuthatha i-benfotiamine ixesha elide, kukho ukuxhalabisa ukuba i-benfotiamine isongezelelo ingabangela imiphumo ethile yecala (njengokusondeza isisu, isisulu, isisu, ukulahleka kweenwele, ukufumana ubunzima, ukuvumba komzimba kunye nokunciphisa uxinzelelo lwegazi).
Abantu abanomzwelo kwisulfure kufuneka baphephe i-benfotiamine.
Inqanaba elikhuselekileyo nelona lifanelekileyo le-benfotiamine lingaziwa ngoku. Ukuba ucinga ngokuxhaswa, thetha nomboneleli wakho wezempilo ukuze ubone ukuba yiyiphi na, ukuba kukho, umlinganiselo we-benfotiamine ulungile kuwe.
Kwakhona, khumbula ukuba ukhuseleko lwezongezelelo kwabasetyhini abakhulelweyo, oomama abancinci, abantwana, kunye nalabo abanezifo zonyango okanye abathabatha imishanguzo ayilwanga. Unokufumana amacebiso amaninzi ekusebenziseni izongezo apha .
Kuphi ukuwufumana
Ukufumaneka ngokubanzi ekuthengeni i-intanethi, izongezelelo ze-benfotiamine zingaphinde zitholwe kwiindawo ezininzi zokutya ezendalo kunye nakwiivenkile ezikhethekileyo kwizibonelelo zokutya.
I-Takeaway
Nangona i-benfotiamine ingaba isongezelelo esithembisayo se-Alzheimer's disease, isifo sikashukela, kunye nezinye iimeko ezibandakanya ukuphela kweemveliso-mveliso, akukho zonke iifundo ezibonise inzuzo. Asikwazi ukuqina malunga nokuxhomekeka kude kube nezilingo ezinkulu zeeklinikhi.
Inani leendidi ekudleni liphandwa kwakhona njengoko kunokwenzeka i-AGE inhibitors. Ngokomzekelo, uphando lwangaphambili lubonisa ukuba i-quercetin (efunyenwe kwi-capers, anyanisi, i-cranberries, ne-apulo), iekatekini (kwi-green tea), kunye ne-resveratrol (kwiidiliya ezibomvu, i-blueberries, iwayini elibomvu kunye ne-tsholeta emnyama) inokuvimbela ama-AGE. Ukuphepha ukutya okuphezulu kwii-AGE kungaphumelela ngendlela ende.
Imithombo:
> Alkhalaf A, Kleefstra N, Groenier KH, et al. Impembelelo ye-benfotiamine kwiiprojekiti eziphambili ze-glycation kunye neempawu zokuphela kokungasebenzi kunye nokuvuvukala kwi-nephropathy yesifo sikashukela. PLoS One. 2012; 7 (7): e40427.
> Alkhalaf A, Klooster A, van Oeveren W, et al. Isivivinyo esine-double-blind, randomized, esilawulwa yi-placebo esilawulwayo kwi-benfotiamine unyango kwizigulane ezine-nephropathy yesifo sikashukela. Uncedo lweSwekile. 2010 Julayi; 33 (7): 1598-601.
> Fraser DA, iDiep LM, uHovden IA, et al. Imiphumo yesongezelelo somlomo we-benfotiamine ngomlomo wexesha elide kumsebenzi wentsholongwane kunye neempawu zokuvuvukala kwizigulane ezine-type 1 zeswekile: iinyanga ezingama-24, i-double-blind, i-randomized, i-placebo elawulwa yilingo. Uncedo lweSwekile. Ngomhla ka-Meyi 2012 (35): 1095-7.
> I-Pan X, u-Chen Z, uFii G, no-al. Ukuphuculwa kweCognitive yexesha elide Emva kolawulo lweBenfotiamine kwizigulane ezinezifo ze-Alzheimer's. Neurosci Bull. Ngo-2016 Dec; 32 (6): 591-596.
> Ukuziphendulela: Ulwazi oluqulethwe kule ndawo lujoliswe kwiinjongo zemfundo kuphela kwaye alithathi indawo yeengcebiso, ukuxilongwa okanye unyango ngumgqirha onikwe ilayisenisi. Akunakuthetha ukukhusela zonke iindlela zokulondoloza, ukusebenzisana kwezidakamizwa, iimeko kunye nemiphumo emibi. Kufuneka uncede unyango lwangonyango ngokukhawuleza kuyo nayiphi na imiba yempilo uze ubonane nodokotela wakho ngaphambi kokusebenzisa elinye iyeza okanye wenze utshintsho kwi-regimen yakho.